novavax, inc. is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. our recombinant nanoparticles and matrix-m™ adjuvant technology are the foundation for groundbreaking innovation that 

Novavax Inc

New position in NVAX

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Swapnil Patel

Sold all NVAX

Sold 50% of NVAX

Isaac Apea

Bought 1160000% more NVAX

Riley Wong

Bought 100% more NVAX

Sold 60% of NVAX

Sold 17% of NVAX